- Home
- >
- Investors
Presentation
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
Adocia is a French clinical-stage biotech company. The core activities of the company are to innovate, to discover and to develop new therapeutic solutions to improve the lives of people suffering from chronic metabolic diseases, such as diabetes and obesity.
ADOCIAADOC.PA
1,20%
5,90 €
Source: Forex
Latest press releases
ADOCIA annonce sa participation à des conférences investisseurs en 2025
12/23/2024
ADOCIA Announces Its Participation at Upcoming Investor Conferences in 2025
12/23/2024
ADOCIA and Tonghua Dongbao Announce the Final Dosing in a Phase 3 Clinical Study of BioChaperone® Lispro, Milestone Associated with a $10 Million Payment
12/12/2024